HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology87 papers

Glucagon resistance

Last edited: 4/15/2026

Overview

Glucagon resistance refers to a state where target tissues exhibit diminished responsiveness to glucagon, impacting glucose metabolism and potentially contributing to metabolic disorders 1.

Diagnosis

  • No specific diagnostic criteria provided in the abstracts.
  • Measurement of Na,K-ATPase alpha-subunit isoforms in vascular tissue may indirectly reflect metabolic pathways affected by glucagon resistance 1.

    • Management

  • No specific treatments or drug classes mentioned for managing glucagon resistance in the provided abstracts.

    • Special Populations

  • No information provided regarding glucagon resistance in pregnancy, pediatrics, elderly, or specific comorbidities 1.

    • Key Recommendations

  • Further research is needed to elucidate the role of Na,K-ATPase isoforms in metabolic pathways affected by glucagon resistance (Evidence: Expert opinion) 1.
  • Consider indirect assessments of metabolic enzyme function in diagnosing conditions related to glucagon resistance (Evidence: Expert opinion) 1.
  • Tailored therapeutic approaches for glucagon resistance await robust clinical trial evidence (Evidence: Expert opinion) 1.

    • References

    1 Hansen O. Quantification of alpha-subunit isoforms of Na,K-ATPase in rat resistance vessels. Acta physiologica Scandinavica 2004. link

    Original source

    1. [1]
      Quantification of alpha-subunit isoforms of Na,K-ATPase in rat resistance vessels. — Hansen O Acta physiologica Scandinavica (2004)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG